Abstract: This study sought to describe a glaucoma patient with interface fluid syndrome (IFS) induced by uncontrolled intraocular pressure (IOP) without triggering factors after laser in situ keratomileusis (LASIK).
INTRODUCTION

I
nterface fluid syndrome (IFS) can develop after laser in situ keratomileusis (LASIK). If IFS occurs, intraocular pressure (IOP) measurements become unreliable. As a result, glaucomatous optic neuropathy progresses, followed by a detectable increase in IOP and a rapid decline in visual function. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Reports have described IFS cases resulting from increased IOP secondary to postoperative steroid administration [1] [2] [3] [4] [5] [6] 10 or to corneal endothelial dysfunction triggered by scleral buckling surgery for retinal detachment, 7, 8 a shallow anterior chamber after trabeculectomy, 9 or uveitis. 11 To our knowledge, no reports have described the development of IFS because of uncontrolled IOP after LASIK during glaucoma management in the absence of these triggering factors. In this study, we report on a patient who underwent LASIK after IOP had been controlled using topical antiglaucoma medications. Two years later, despite the absence of triggers such as steroid use or a history of previous ocular surgery, IFS developed in association with IOP elevation and marked loss of visual function.
PRESENTING CONCERNS
A 23-year-old man was diagnosed with glaucoma at an eye clinic in January 2009 based on elevated IOP in the right eye, and treatment with an unspecified topical antiglaucoma medication was initiated. One month later, the patient was informed that the IOP had normalized, and he spontaneously terminated the use of antiglaucoma eye drops. Approximately 6 months later, the patient underwent LASIK for myopia at a LASIK center. He underwent several medical examinations after LASIK, but he did not report glaucoma at that center. Therefore, he had not used any antiglaucoma medication after LASIK. In September 2010, an eye doctor at another clinic measured an IOP of 29 mm Hg in the right eye and 16 mm Hg in the left eye using noncontact tonometer (NCT). Topical latanoprost 0.005% (Pfizer Inc, New York, NY) once daily and topical timolol maleate 0.5% twice daily in the right eye were initiated, and the patient was referred to Kitasato University Hospital for further management.
CLINICAL FINDINGS
At the hospital, Goldmann applanation tonometry (GAT) revealed IOPs of 13 and 14 mm Hg, and NCT revealed IOPs of 13.9and 15.2 mm Hg in the right and the left eye, respectively.
No opacity or edema was observed in the flap or the interface, and there was no inflammation in the anterior chamber. Gonioscopy indicated an open angle. Funduscopy revealed cup-todisc ratios of approximately 0.9 in the right eye, along with superior and inferior rim thinning, and 0.7 in the left eye. An attached referral form indicated that the Humphrey Field Analyzer (HFA; Carl Zeiss Meditec Inc, Dublin, CA) mean deviations (MDs) were À25.28 dB in the right eye and À1.85 dB in the left eye using the Swedish interactive threshold algorithm standard 30-2 program.
The patient's medical history revealed that before undergoing LASIK, the patient had worn contact lenses to correct À8 diopters (D) of myopia, with the assumption that the measured IOP of 4 to 5 mm Hg was underestimated. 12 On follow-up, the IOP in the right eye decreased to 9 to 11 mm Hg (GAT) until December 2010.
On June 6, 2011, the patient presented to our hospital because of significantly blurred vision. The visual acuity (VA) of the right eye was hand motion, and GAT measurement was impossible because the inner edges of the 2 fluorescein semicircles in the prism head were blurred and irresolvable. The IOP was presumed to be high (at least 30 mm Hg) based on digital palpation and the positioning of the outer edges of the fluorescein semicircles. An intravenous mannitol drip was immediately administered, and the IOP decreased to 24.0 mm Hg, as measured using an NCT. Oral acetazolamide (500 mg/d and 2 types of antiglaucoma eye drops were prescribed.
DIAGNOSTIC FOCUS AND ASSESSMENT
On June 13, 2011, GAT measurement of the right eye remained impossible. The IOP measured using an NCT was 33.7 mm Hg. Pachymetry measurements indicated that the central corneal thickness was 540 mm in the right eye and 490 mm in the left eye. The corneal endothelial cell densities were 2414/mm 2 in the right eye and 2521/mm 2 in the left eye. Minimal opacity was detected in the flap interface, and no substantial water gap was observed based on slit-lamp examination ( Figure 1) ; however, an optically empty space corresponding to an interface fluid pocket was detected using AXSUN anterior optical coherence tomography (Kitasato University, Kanagawa, Japan). 13 IFS was diagnosed based on these clinical findings and the patient's clinical course.
THERAPEUTIC FOCUS AND ASSESSMENT
On July 13, 2011, a trabeculectomy with mitomycin C (MMC) was performed on the patient's right eye. The IOP of the right eye was measured postoperatively by GAT. This pressure remained stable at 2 mm Hg for 1 month; subsequently, an average IOP of 5 mm Hg was maintained during the first postoperative year. No apparent hypotonic maculopathy was observed. The corneal flap interface was wrinkled. After surgery, VA improved slightly from the preoperative level of light projection to hand motion. A temporal island of the visual field, as measured by Goldmann kinetic perimetry, remained unchanged after surgery.
On July 23, 2012, IOP was stable at 5 mm Hg in the right eye, but was increased to 37 mm Hg (as measured by GAT) in the left eye, accompanied by minimal corneal edema. Systemic acetazolamide (750 mg/d) was prescribed, but was insufficiently effective. No symptoms of IFS were observed in the right eye; however, a trabeculectomy with MMC was performed on the patient's left eye on August 1, 2012.
FOLLOW-UP AND OUTCOMES
In July 2013, the IOPs were 6 mm Hg in the right eye and 7 mm Hg in the left eye (as measured by GAT). At this time point, the right eye VA was hand motion, whereas the uncorrected VA of the left eye was 1.2 (20/16). A fold was observed on the corneal flap interface in the right eye 2 years postoperatively; this fold diminished over time, but did not completely resolve. No 
DISCUSSION
IFS, which is associated with inaccurately low measurements of central IOP 1-3,5-8 because of cushioning of the fluidfilled pocket, 5 can result from increased IOP secondary to postoperative steroid use [1] [2] [3] [4] [5] [6] 10 or corneal endothelial dysfunction after vitreous surgery 7, 8 or trabeculectomy. 9 A study of human eye bank corneas reported 2 mechanisms of IFS: increased IOP (the high-IOP form of IFS) and corneal endothelial dysfunction (the endothelial cell damage form of IFS).
14 In the current case, no steroid treatment was administered before the onset of IFS, and specular microscopy produced unremarkable findings. This case was classified as the high-IOP form of IFS despite a minimal increase in corneal thickness and opacity under the flap because there was no opacity or edema in the flap itself. Both Hamilton et al 3 and Kang et al 9 reported that IFS is associated with glaucoma, but the mechanisms underlying IFS differed between these 2 studies. The former report indicated that IOP increased with steroid use, whereas the latter report cited corneal endothelial dysfunction resulting from aggressive surgery and 5-fluorouracil intervention as the possible cause of increased IOP. The case described here may be the first reported instance in which IFS developed because of uncontrolled IOP during glaucoma management in the absence of triggering factors such as steroid-induced IOP elevation or corneal endothelial dysfunction.
Dawson et al 14 classified IFS into stages ranging from 0 to 3 based on the degree of fluid retention in the flap interface. Using this staging system, the right eye in the current case would be classified as stage 2; the left eye would be categorized as stage 1, which is often referred to as pressure-induced interlamellar stromal keratitis. 15 A trabeculectomy was performed >5 weeks after IOP increased in the right eye. Owing to this delay, the corneal flap might have been stretched by the interface fluid that had accumulated under the flap. As a result, even after the interface fluid was absorbed and the space under the flap decreased, the stretched flap did not recover, leading to shriveling of the flap and the sustained presence of a fold at 2 years after surgery (Figure 2 ). Because the central visual field was lost in the right eye, it was impossible to determine how the corneal fold affected the vision of this patient; however, if a corneal fold had developed in the left eye, we would predict a delay in visual recovery.
Unfortunately, the VA of the right eye in this patient became hand motion. We must investigate the reason why the vision in his right eye was nearly lost. One reason could be the fact that he stopped seeing a doctor and terminated his use of antiglaucoma medication because he was informed that the IOP had normalized. Once patients are diagnosed with glaucoma, they must continue to be followed by doctors throughout their lives. It is possible that the explanation provided by the doctor at the first clinic regarding the disease of glaucoma was insufficient. Another reason could be that LASIK was performed on the eye without sufficient information about the probability of glaucoma progression and the difficulty of glaucoma management after LASIK. It is well known that the IOP is often underestimated after LASIK. 12, 16, 17 In this case, on the first visit to our hospital, IOP measurements of 13 mm Hg in the right eye and 14 mm Hg in the left eye were obtained via GAT. Given the power of the contact lenses (À8 D) before LASIK surgery, underestimation by approximately 4 mm Hg is thought to occur. 12 This result suggests that the corrected IOP might be approximately 17 to 18 mm Hg. According to the target IOP used in the Advanced Glaucoma Intervention Study, 18 the IOP in this patient first reached the targeted IOP. However, to predict the appropriate IOP to be maintained for the management of glaucoma in this case, IOP and the visual field should be monitored for a prolonged period. Even if there had been no elevation of IOP, reducing the IOP might have been necessary in the current case. The determination of whether or not treatment is required should be based on frequent medical evaluation and examination. However, one must consider the possibility of an increase in IOP because it is not easy to control IOP based on underestimated IOP measurements using GAT. Cases with normal tension glaucoma are unlikely to develop IFS as occurred in this case because the increase in IOP in this case is unusual. Alternatively, in glaucoma cases involving a prior increase in IOP, IOP can continue to increase during the disease course even if temporary control of IOP has been achieved. If LASIK is performed in such cases, the treatment may be insufficient because of underestimation of the typical IOP. In fact, the measurement of IOP can become difficult at high-IOP levels. Furthermore, serious visual disorders can develop. Thus, LASIK should not be performed on eyes with glaucoma because of the high risk of elevated IOP.
